A large retrospective study across 38 endocrinology clinics in Turkey showed that liraglutide led to meaningful weight loss and metabolic improvements—even at slightly reduced doses. Hear from ReachMD's Ryan Quigley as he reviews recent real-world data on this GLP-1 receptor agonist.

Clinician's Roundtable Real-World Effectiveness of Liraglutide for Obesity: Multicenter Data From Turkey
Oct 24, 2025
Chapters
Transcript
Episode notes
